Computer-Aided Drug Design Is A Relatively New Field In Which Computer Software Is Used To Design Drugs That Can Successfully Bind With Their Target Molecules And Thus Produce A Desired Effect. By Analyzing Data From Experiments Conducted On Existing Drugs, Software Can Generate Models Of Drug Molecules, And Chemical Energy Fields And Generated Structural Information Are Used To Choose Drug Candidates. In This Way, Computer-Aided Drug Design Enables Scientists To Identify And Select Potential Drug Molecules From A Vast Range Of Molecules To Develop For Further Testing. Computer-Aided Drug Design Uses Numerous Algorithms To Generate Structural Data And Model Drug Molecules. Molecular Modelling Algorithms Can Be Used To Fill In Missing Data Points Or Derive New Information From Existing Data Points. These Can Include Docking Algorithms Which Determine How Molecules Can Fit Into A Given Receptor And Pharmacophore-Based Algorithms Which Identify Small Chemical Groups Commonly Found In Drugs. Machine Learning Techniques Can Also Be Used To Rapidly Find And Generate Results That Provide Further Information About Potential Therapeutic Targets Or Side Effects. Computer-Aided Drug Design Also Involves Virtual Screening Techniques, In Which Models Of Potential Drug Molecules Are Used To Identify The Most Promising Compounds. Ab Initio Simulations Can Be Used To Simulate The Interaction Of Drug Molecules With Their Therapeutic Targets And Molecular Dynamics Simulations Can Be Performed To Determine How Drug Molecules Will Interact In Biological Systems. Overall, Computer-Aided Drug Design Is A Versatile And Powerful Tool For Drug Discovery Which Reduces The Time And Cost Of Drug Development And Makes It Easier To Identify The Most Promising Drug Compounds. By Providing Scientists With More Accurate And Detailed Information About Potential Therapeutic Targets And Drug Interactions, Computer-Aided Drug Design Offers Tremendous Potential To Advance Drug Development And Shorten The Path To Market.
Title : Fighting antibiotic resistance: Eliminating implant infections in humans without antibiotics
Thomas J Webster, Brown University, United States
Title : Novel polymer-mediated therapeutic options for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Turning problems into opportunities via small molecule design
Brian Blagg, University of Notre Dame, United States
Title : Durable surface-confined metal-terpyridine architectures for electrochromic applications
Olena Zenkina, Ontario Tech University, Canada
Title : Advances in plasma-based waste treatment
Hossam A Gabbar, Ontario Tech University, Canada
Title : Application of the Michaelis-Menten formalism to hydrocracking-related reactions and analysis of the features of the reactors
Orchidea Maria Lecian, Sapienza University of Rome, Italy